Phosphoinositides: Important lipids in the coordination of cell dynamics

Biochimie

Volumn 125, Issue , 2016, Pages 250-258

  Viaud, Julien ^a   Mansour, Rana ^a   Antkowiak, Adrien ^a   Mujalli, Abdulrahman ^a   Valet, Colin ^a   Chicanne, Gaëtan ^a   Xuereb, Jean Marie ^a   Terrisse, Anne Dominique ^a   Séverin, Sonia ^a   Gratacap, Marie Pierre ^a   Gaits Iacovoni, Frédérique ^a   Payrastre, Bernard ^a,b  

^a Université de Toulouse   (France)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

Cell signaling; Lipids; Pathologies; Phosphoinositide metabolizing enzymes; Phosphoinositides; PI3K

Indexed keywords

PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE BETA; PHOSPHATIDYLINOSITOL 3 KINASE DELTA; PHOSPHATIDYLINOSITOL 3,4 BISPHOSPHATE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; UNCLASSIFIED DRUG; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLINOSITOL KINASE; TUMOR PROTEIN;

ACTIN FILAMENT; ANION EXCHANGE CHROMATOGRAPHY; ARTERY THROMBOSIS; AUTOPHAGOSOME; CANCER THERAPY; CELL MEMBRANE; CHRONIC LYMPHATIC LEUKEMIA; COMPLEX FORMATION; CYTOSKELETON; ECTOPIC EXPRESSION; ENDOCYTOSIS; EXOCYTOSIS; GAIN OF FUNCTION MUTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTRACELLULAR SIGNALING; LIPID METABOLISM; LOSS OF FUNCTION MUTATION; MASS SPECTROMETRY; MOLECULAR DYNAMICS; NONHODGKIN LYMPHOMA; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REVIEW; SOMATIC MUTATION; SPATIOTEMPORAL ANALYSIS; THIN LAYER CHROMATOGRAPHY; ANIMAL; GENETIC DISORDER; GENETICS; INFECTION; METABOLISM; NEOPLASM; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 4-KINASE; ANIMALS; GENETIC DISEASES, INBORN; HUMANS; INFECTION; NEOPLASM PROTEINS; NEOPLASMS; PHOSPHATIDYLINOSITOLS; SIGNAL TRANSDUCTION;

EID: 84968879180     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2015.09.005     Document Type: Review

References (102)

1. Y. Sun, N. Thapa, A.C. Hedman, and R.A. Anderson Phosphatidylinositol 4,5-bisphosphate: targeted production and signaling BioEssays News Rev. Mol. Cell. Dev. Biol. 35 2013 513 522
2. R.S. Salamon, and J.M. Backer Phosphatidylinositol-3,4,5-trisphosphate: tool of choice for class I PI 3-kinases BioEssays News Rev. Mol. Cell. Dev. Biol. 35 2013 602 611
3. K.O. Schink, C. Raiborg, and H. Stenmark Phosphatidylinositol 3-phosphate, a lipid that regulates membrane dynamics, protein sorting and cell signalling BioEssays News Rev. Mol. Cell. Dev. Biol. 35 2013 900 912
4. M.A. De Matteis, C. Wilson, and G. D'Angelo Phosphatidylinositol-4-phosphate: the Golgi and beyond BioEssays News Rev. Mol. Cell. Dev. Biol. 35 2013 612 622
5. A. Gassama-Diagne, and B. Payrastre Phosphoinositide signaling pathways: promising role as builders of epithelial cell polarity Int. Rev. Cell Mol. Biol. 273 2009 313 343
6. M. Falasca, and et al. The role of phosphoinositide 3-kinase C2alpha in insulin signaling J. Biol. Chem. 282 2007 28226 28236
7. C. Valet, and et al. Essential role of class II PI3K-C2alpha in platelet membrane morphology Blood 126 2015 1128 1137
8. I. Ivetac, and et al. The type Ialpha inositol polyphosphate 4-phosphatase generates and terminates phosphoinositide 3-kinase signals on endosomes and the plasma membrane Mol. Biol. Cell 16 2005 2218 2233
9. J.E. Slessareva, S.M. Routt, B. Temple, V.A. Bankaitis, and H.G. Dohlman Activation of the phosphatidylinositol 3-kinase Vps34 by a G protein alpha subunit at the endosome Cell 126 2006 191 203
10. A. Kihara, T. Noda, N. Ishihara, and Y. Ohsumi Two distinct Vps34 phosphatidylinositol 3-kinase complexes function in autophagy and carboxypeptidase Y sorting in Saccharomyces cerevisiae J. Cell Biol. 152 2001 519 530
11. L. Tawk, and et al. Phosphatidylinositol 3-phosphate, an essential lipid in Plasmodium, localizes to the food vacuole membrane and the apicoplast Eukaryot. Cell 9 2010 1519 1530
12. G. Chicanne, and et al. A novel mass assay to quantify the bioactive lipid PtdIns3P in various biological samples Biochem. J. 447 2012 17 23
13. T. Proikas-Cezanne, Z. Takacs, P. Donnes, and O. Kohlbacher WIPI proteins: essential PtdIns3P effectors at the nascent autophagosome J. Cell Sci. 128 2015 207 217
14. V. Dominguez, and et al. Class II phosphoinositide 3-kinase regulates exocytosis of insulin granules in pancreatic beta cells J. Biol. Chem. 286 2011 4216 4225
15. C. Ellson, K. Davidson, K. Anderson, L.R. Stephens, and P.T. Hawkins PtdIns3P binding to the PX domain of p40phox is a physiological signal in NADPH oxidase activation EMBO J. 25 2006 4468 4478
16. A.P. Sagona, and et al. PtdIns(3)P controls cytokinesis through KIF13A-mediated recruitment of FYVE-CENT to the midbody Nat. Cell Biol. 12 2010 362 371
17. D. Lu, and et al. Phosphatidylinositol 4-kinase IIalpha is palmitoylated by Golgi-localized palmitoyltransferases in cholesterol-dependent manner J. Biol. Chem. 287 2012 21856 21865
18. Y.J. Wei, and et al. Type II phosphatidylinositol 4-kinase beta is a cytosolic and peripheral membrane protein that is recruited to the plasma membrane and activated by Rac-GTP J. Biol. Chem. 277 2002 46586 46593
19. A. Godi, and et al. ARF mediates recruitment of PtdIns-4-OH kinase-beta and stimulates synthesis of PtdIns(4,5)P2 on the Golgi complex Nat. Cell Biol. 1 1999 280 287
20. A. Hausser, and et al. Phospho-specific binding of 14-3-3 proteins to phosphatidylinositol 4-kinase III beta protects from dephosphorylation and stabilizes lipid kinase activity J. Cell Sci. 119 2006 3613 3621
21. A. Blagoveshchenskaya, and et al. Integration of Golgi trafficking and growth factor signaling by the lipid phosphatase SAC1 J. Cell Biol. 180 2008 803 812
22. M. de Saint-Jean, and et al. Osh4p exchanges sterols for phosphatidylinositol 4-phosphate between lipid bilayers J. Cell Biol. 195 2011 965 978
23. G. D'Angelo, M. Vicinanza, A. Di Campli, and M.A. De Matteis The multiple roles of PtdIns(4)P - not just the precursor of PtdIns(4,5)P2 J. Cell Sci. 121 2008 1955 1963
24. L. Demmel, and et al. The clathrin adaptor Gga2p is a phosphatidylinositol 4-phosphate effector at the Golgi exit Mol. Biol. Cell 19 2008 1991 2002
25. E. Mizuno-Yamasaki, M. Medkova, J. Coleman, and P. Novick Phosphatidylinositol 4-phosphate controls both membrane recruitment and a regulatory switch of the Rab GEF Sec2p Dev. Cell 18 2010 828 840
26. J. Viaud, F. Boal, H. Tronchere, F. Gaits-Iacovoni, and B. Payrastre Phosphatidylinositol 5-phosphate: a nuclear stress lipid and a tuner of membranes and cytoskeleton dynamics BioEssays news Rev. Mol. Cell. Dev. Biol. 36 2014 260 272
27. D. Sarkes, and L.E. Rameh A novel HPLC-based approach makes possible the spatial characterization of cellular PtdIns5P and other phosphoinositides Biochem. J. 428 2010 375 384
28. O. Gozani, and et al. The PHD finger of the chromatin-associated protein ING2 functions as a nuclear phosphoinositide receptor Cell 114 2003 99 111
29. K. Niebuhr, and et al. Conversion of PtdIns(4,5)P(2) into PtdIns(5)P by the S.flexneri effector IpgD reorganizes host cell morphology EMBO J. 21 2002 5069 5078
30. C. Pendaries, and et al. PtdIns5P activates the host cell PI3-kinase/Akt pathway during Shigella flexneri infection EMBO J. 25 2006 1024 1034
31. D. Ramel, and et al. Shigella flexneri infection generates the lipid PI5P to alter endocytosis and prevent termination of EGFR signaling Sci. Signal. 4 2011 ra61
32. F. Boal, and et al. TOM1 is a PI5P effector involved in the regulation of endosomal maturation J. Cell Sci. 128 2015 815 827
33. A. Puhar, H. Tronchere, B. Payrastre, G.T. Nhieu, and P.J.A. Sansonetti Shigella effector dampens inflammation by regulating epithelial release of danger signal ATP through production of the lipid mediator PtdIns5P Immunity 39 2013 1121 1131
34. G. Guittard, and et al. Cutting edge: Dok-1 and Dok-2 adaptor molecules are regulated by phosphatidylinositol 5-phosphate production in T cells J. Immunol. 182 2009 3974 3978
35. D. Sbrissa, O.C. Ikonomov, J. Strakova, and A. Shisheva Role for a novel signaling intermediate, phosphatidylinositol 5-phosphate, in insulin-regulated F-actin stress fiber breakdown and GLUT4 translocation Endocrinology 145 2004 4853 4865
36. J. Viaud, and et al. Phosphatidylinositol 5-phosphate regulates invasion through binding and activation of Tiam1 Nat. Commun. 5 2014 4080
37. M. Vicinanza, and et al. PI(5)P regulates autophagosome biogenesis Mol. Cell 57 2015 219 234
38. J. Xie, C. Erneux, and I. Pirson How does SHIP1/2 balance PtdIns(3,4)P2 and does it signal independently of its phosphatase activity? BioEssays News Rev. Mol. Cell. Dev. Biol. 35 2013 733 743
39. Y. Posor, and et al. Spatiotemporal control of endocytosis by phosphatidylinositol-3,4-bisphosphate Nature 499 2013 233 237
40. H. Li, and A.J. Marshall Phosphatidylinositol (3,4) bisphosphate-specific phosphatases and effector proteins: a distinct branch of PI3K signaling Cell. Signal. 27 2015 1789 1798
41. S. Wullschleger, D.H. Wasserman, A. Gray, K. Sakamoto, and D.R. Alessi Role of TAPP1 and TAPP2 adaptor binding to PtdIns(3,4)P2 in regulating insulin sensitivity defined by knock-in analysis Biochem. J. 434 2011 265 274
42. E. Boucrot, and et al. Endophilin marks and controls a clathrin-independent endocytic pathway Nature 517 2015 460 465
43. M. Krause, and et al. Lamellipodin, an Ena/VASP ligand, is implicated in the regulation of lamellipodial dynamics Dev. Cell 7 2004 571 583
44. T. Oikawa, T. Itoh, and T. Takenawa Sequential signals toward podosome formation in NIH-src cells J. Cell Biol. 182 2008 157 169
45. A.J. McCartney, Y. Zhang, and L.S. Weisman Phosphatidylinositol 3,5-bisphosphate: low abundance, high significance BioEssays News Rev. Mol. Cell. Dev. Biol. 36 2014 52 64
46. D. Sbrissa, O.C. Ikonomov, and A. Shisheva Phosphatidylinositol 3-phosphate-interacting domains in PIKfyve. Binding specificity and role in PIKfyve. Endomenbrane localization J. Biol. Chem. 277 2002 6073 6079
47. K. Hnia, I. Vaccari, A. Bolino, and J. Laporte Myotubularin phosphoinositide phosphatases: cellular functions and disease pathophysiology Trends Mol. Med. 18 2012 317 327
48. J. de Lartigue, and et al. PIKfyve regulation of endosome-linked pathways Traffic 10 2009 883 893
49. Y. Zhang, and et al. Loss of Vac14, a regulator of the signaling lipid phosphatidylinositol 3,5-bisphosphate, results in neurodegeneration in mice Proc. Natl. Acad. Sci. U. S. A. 104 2007 17518 17523
50. A.C. Rutherford, and et al. The mammalian phosphatidylinositol 3-phosphate 5-kinase (PIKfyve) regulates endosome-to-TGN retrograde transport J. Cell Sci. 119 2006 3944 3957
51. M. Thumm, and et al. It takes two to tango: PROPPINs use two phosphoinositide-binding sites Autophagy 9 2013 106 107
52. R. Krick, and et al. Structural and functional characterization of the two phosphoinositide binding sites of PROPPINs, a beta-propeller protein family Proc. Natl. Acad. Sci. U. S. A. 109 2012 E2042 E2049
53. K.M. Vasudevan, and L.A. Garraway AKT signaling in physiology and disease Curr. Top. Microbiol. Immunol. 347 2010 105 133
54. J. Viaud, F. Gaits-Iacovoni, and B. Payrastre Regulation of the DH-PH tandem of guanine nucleotide exchange factor for Rho GTPases by phosphoinositides Adv. Biol. Regul. 52 2012 303 314
55. A. Gassama-Diagne, and et al. Phosphatidylinositol-3,4,5-trisphosphate regulates the formation of the basolateral plasma membrane in epithelial cells Nat. cell Biol. 8 2006 963 970
56. M.A. Lemmon, K.M. Ferguson, and C.S. Abrams Pleckstrin homology domains and the cytoskeleton FEBS Lett. 513 2002 71 76
57. B. Payrastre Phosphoinositides: lipid kinases and phosphatases Methods Mol. Biol. 273 2004 201 212
58. J.B. Morris, K.A. Hinchliffe, A. Ciruela, A.J. Letcher, and R.F. Irvine Thrombin stimulation of platelets causes an increase in phosphatidylinositol 5-phosphate revealed by mass assay FEBS Lett. 475 2000 57 60
59. J. Clark, and et al. Quantification of PtdInsP3 molecular species in cells and tissues by mass spectrometry Nat. Methods 8 2011 267 272
60. G.R. Hammond, G. Schiavo, and R.F. Irvine Immunocytochemical techniques reveal multiple, distinct cellular pools of PtdIns4P and PtdIns(4,5)P(2) Biochem. J. 422 2009 23 35
61. Hélène Tronchère, Alessandra Bolino, Jocelyn Laporte, and Bernard Payrastre Myotubularins and associated neuromuscular diseases Clin. Lipidol. 7 2012 151 162
62. D.A. Fruman, and C. Rommel PI3K and cancer: lessons, challenges and opportunities Nat. Rev. Drug Discov. 13 2014 140 156
63. S.J. Leevers, B. Vanhaesebroeck, and M.D. Waterfield Signalling through phosphoinositide 3-kinases: the lipids take centre stage Curr. Opin. Cell Biol. 11 1999 219 225
64. M. Whitman, C.P. Downes, M. Keeler, T. Keller, and L. Cantley Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate Nature 332 1988 644 646
65. L.C. Cantley The phosphoinositide 3-kinase pathway Science 296 2002 1655 1657
66. B. Pasquier SAR405, a PIK3C3/Vps34 inhibitor that prevents autophagy and synergizes with MTOR inhibition in tumor cells Autophagy 11 2015 725 726
67. Y. Samuels, and et al. High frequency of mutations of the PIK3CA gene in human cancers Science 304 2004 554
68. L. Zhao, and P.K. Vogt Helical domain and kinase domain mutations in p110alpha of phosphatidylinositol 3-kinase induce gain of function by different mechanisms Proc. Natl. Acad. Sci. U. S. A. 105 2008 2652 2657
69. G. Mirzaa, R. Conway, J.M. Graham Jr., and W.B. Dobyns R.A. Pagon, GeneReviews(R) 1993 (Seattle (WA)
70. D.W. Cescon, C. Gorrini, and T.W. Mak Breaking up is hard to do: PI3K isoforms on the rebound Cancer Cell 27 2015 5 7
71. S.T. Jou, and et al. Essential, nonredundant role for the phosphoinositide 3-kinase p110delta in signaling by the B-cell receptor complex Mol. Cell. Biol. 22 2002 8580 8591
72. D.A. Fruman, and C. Rommel PI3Kdelta inhibitors in cancer: rationale and serendipity merge in the clinic Cancer Discov. 1 2011 562 572
73. A.K. Gopal, and et al. PI3Kdelta inhibition by idelalisib in patients with relapsed indolent lymphoma N. Engl. J. Med. 370 2014 1008 1018
74. R.R. Furman, and et al. Idelalisib and rituximab in relapsed chronic lymphocytic leukemia N. Engl. J. Med. 370 2014 997 1007
75. C.M. Walsh, and D.A. Fruman Too much of a good thing: immunodeficiency due to hyperactive PI3K signaling J. Clin. Invest. 124 2014 3688 3690
76. K. Ali, and et al. Inactivation of PI(3)K p110delta breaks regulatory T-cell-mediated immune tolerance to cancer Nature 510 2014 407 411
77. M.P. Gratacap, and et al. Regulation and roles of PI3Kbeta, a major actor in platelet signaling and functions Adv. Enzyme Regul. 51 2011 106 116
78. S.P. Jackson, and et al. PI 3-kinase p110beta: a new target for antithrombotic therapy Nat. Med. 11 2005 507 514
79. I. Canobbio, and et al. Genetic evidence for a predominant role of PI3Kbeta catalytic activity in ITAM- and integrin-mediated signaling in platelets Blood 114 2009 2193 2196
80. V. Martin, and et al. Deletion of the p110beta isoform of phosphoinositide 3-kinase in platelets reveals its central role in Akt activation and thrombus formation in vitro and in vivo Blood 115 2010 2008 2013
81. A. Consonni, and et al. Role and regulation of phosphatidylinositol 3-kinase beta in platelet integrin alpha2beta1 signaling Blood 119 2012 847 856
82. S.P. Jackson, and S.M. Schoenwaelder Antithrombotic phosphoinositide 3-kinase beta inhibitors in humans: a 'shear' delight! J. Thromb. Haemost. JTH 10 2012 2123 2126
83. S. Nylander, and et al. Human target validation of phosphoinositide 3-kinase (PI3K)beta: effects on platelets and insulin sensitivity, using AZD6482 a novel PI3Kbeta inhibitor J. Thromb. Haemost. JTH 10 2012 2127 2136
84. S. Nylander, F. Wagberg, M. Andersson, T. Skarby, and D. Gustafsson Exploration of efficacy and bleeding with combined phosphoinositide 3-kinase beta inhibition and aspirin in man J. Thromb. Haemost 13 2015 1494 1502
85. P.A. Laurent, and et al. Platelet PI3Kbeta and GSK3 regulate thrombus stability at a high shear rate Blood 125 2015 881 888
86. M. Torti PI3Kbeta inhibition: all that glitters is not gold Blood 125 2015 750 751
87. O. Attree, and et al. The Lowe's oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphatase Nature 358 1992 239 242
88. R.R. Hoopes Jr., and et al. Dent Disease with mutations in OCRL1 Am. J. Hum. Genet. 76 2005 260 267
89. G. Narkis, and et al. Lethal contractural syndrome type 3 (LCCS3) is caused by a mutation in PIP5K1C, which encodes PIPKI gamma of the phophatidylinsitol pathway Am. J. Hum. Genet. 81 2007 530 539
90. L. Amoasii, K. Hnia, and J. Laporte Myotubularin phosphoinositide phosphatases in human diseases Curr. Top. Microbiol. Immunol. 362 2012 209 233
91. S. Li, and et al. Mutations in PIP5K3 are associated with Francois-Neetens mouchetee fleck corneal dystrophy Am. J. Hum. Genet. 77 2005 54 63
92. C.A. Worby, and J.E. Dixon Pten. Annu. Rev. Biochem. 83 2014 641 669
93. J.E. Burke, and R.L. Williams Synergy in activating class I PI3Ks Trends Biochem. Sci. 40 2015 88 100
94. N. Al Tassan, and et al. A missense mutation in PIK3R5 gene in a family with ataxia and oculomotor apraxia Hum. Mutat. 33 2012 351 354
95. M.E. Conley, and et al. Agammaglobulinemia and absent B lineage cells in a patient lacking the p85alpha subunit of PI3K J. Exp. Med. 209 2012 463 470
96. I. Angulo, and et al. Phosphoinositide 3-kinase delta gene mutation predisposes to respiratory infection and airway damage Science 342 2013 866 871
97. J.B. Riviere, and et al. De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes Nat. Genet. 44 2012 934 940
98. S. Fernandes, S. Iyer, and W.G. Kerr Role of SHIP1 in cancer and mucosal inflammation Ann. N. Y. Acad. Sci. 1280 2013 6 10
99. A. Suwa, T. Kurama, and T. Shimokawa SHIP2 and its involvement in various diseases Expert Opin. Ther. Targets 14 2010 727 737
100. E.C. Chai, and R.R. Singaraja Opsismodysplasia: implications of mutations in the developmental gene INPPL1 Clin. Genet. 83 2013 527 529
101. M. Jacoby, and et al. INPP5E mutations cause primary cilium signaling defects, ciliary instability and ciliopathies in human and mouse Nat. Genet. 41 2009 1027 1031
102. E.L. Clayton, S. Minogue, and M.G. Waugh Phosphatidylinositol 4-kinases and PI4P metabolism in the nervous system: roles in psychiatric and neurological diseases Mol. Neurobiol. 47 2013 361 372